期刊文献+

miR-802靶向调控PI3K/Akt信号通路促进肝细胞癌血管新生的机制研究 被引量:1

Mechanism of miR-802 targeting PI3K/Akt signaling pathway in promoting angiogenesis of hepatocellular carcinoma
下载PDF
导出
摘要 目的 探究miR-802在肝细胞癌(HCC)细胞中的表达及其对肿瘤血管新生的影响及作用机制。方法 通过转染miR-802 agomir、miR-802 antagomir上调或抑制人HCC细胞系SMMC-7721中mi R-802的表达水平。将SMMC-7721细胞分为NC组(正常培养细胞)、miR-802 agomir组(转染mi R-802 agomir)和miR-802antagomir组(转染miR-802 antagomir)。采用小管形成实验和Transwell实验检测过表达miR-802的SMMC-7721细胞上清液对人脐静脉内皮细胞(HUVEC)成管能力及迁移能力的影响。采用蛋白质印迹法检测mi R-802 agomir组中磷脂酰肌醇3激酶(PI3K)、磷酸化PI3K(p-PI3K)、蛋白激酶B(Akt)、磷酸化Akt(p-Akt)、血管内皮生长因子(VEGF)的表达水平。采用免疫荧光实验检测过表达miR-802对VEGF生成的影响。结果 与NC组相比,mi R-802 agomir组HUVEC细胞的成管能力及迁移能力均显著增强,miR-802 antagomir组HUVEC细胞的成管能力及迁移能力均显著降低,差异均有统计学意义(P均<0.05)。与NC组相比,miR-802 agomir组SMMC-7721细胞中VEGF生成量增加,p-PI3K、p-Akt、Akt蛋白表达水平均显著升高,差异均有统计学意义(P均<0.05)。结论 miR-802可通过调控PI3K/Akt信号通路促进VEGF的释放,参与血管新生,从而促进HCC的发生和进展。 Objective This paper attempts to investigate the expression of miR-802 in hepatocellular carcinoma cells and its effect on tumor angiogenesis and mechanism of action.Methods The expression of miR-802 in human hepatocellular carcinoma cell line SMMC-7721 was up-regulated or inhibited by transfection of miR-802 agomir and miR-802 antagomir.SMMC-7721 cells were divided into the NC group(normal cultured cells),the miR-802 agomir group(transfected with miR-802 agomir),and the miR-802 antagomir group(transfected with miR-802 antagomir).The effects of SMMC-7721 cell supernatant overexpressing miR-802 on the tube-forming and migratory abilities of human umbilical vein endothelial cells(HUVEC)were detected by using tubule formation assay and Transwell assay.The expression of phosphatidylinositol 3-kinase(PI3K),phosphorylated PI3K(p-PI3K),protein kinase B(Akt),phosphorylated Akt(p-Akt),and vascular endothelial growth factor(VEGF)was detected by western blotting in the miR-802 agomir group.Immunofluorescence assay was used to detect the effect of overexpression of miR-802 on VEGF production.Results Compared with the NC group,the tube-forming and migratory abilities of HUVEC cells in the miR-802 agomir group are enhanced,and the tube-forming and migratory abilities of HUVEC cells in the miR-802 antagomir group are reduced,with statistically significant differences(P<0.05).Compared with the NC group,the production of VEGF of SMMC-7721 cells in the miR-802 agomir group is increased,and the protein expression of p-PI3K,p-Akt,and Akt is elevated,with statistically significant differences(P<0.05).Conclusion miR-802 can promote the release of VEGF through regulating the PI3K/Akt signaling pathway,and then participate in angiogenesis,thus promoting the occurrence and progression of hepatocellular carcinoma.
作者 刘文豪 倪敏 沈甫明 金涌 LIU Wenhao;JIN Yong;NI Min;SHEN Fuming(School of Pharmacy,Anhui Medical University,Hefei 230032,China;Department of Pharmacy,Tenth People's Hospital of Tongji University,Shanghai 200072,China)
出处 《国际消化病杂志》 CAS 2024年第1期42-47,共6页 International Journal of Digestive Diseases
基金 上海市崇明区“可持续发展科技创新行动计划”项目(CKY2022-24)。
关键词 肝细胞癌 miR-802 血管新生 PI3K/AKT信号通路 Hepatocellular carcinoma miR-802 Angiogenesis PI3K/Akt signaling pathway
  • 相关文献

参考文献4

二级参考文献23

  • 1Chang Liu,Guang-Qin Xiao,Lu-Nan Yan,Bo Li,Li Jiang,Tian-Fu Wen,Wen-Tao Wang,Ming-Qing Xu,Jia-Yin Yang.Value of α-fetoprotein in association with clinicopathological features of hepatocellular carcinoma[J].World Journal of Gastroenterology,2013,19(11):1811-1819. 被引量:23
  • 2孙业全,王滨,李绪斌,蹇兆成.肝动脉化疗栓塞对肝癌细胞黏附分子CD44v6和ICAM-1表达的影响[J].中国中西医结合影像学杂志,2007,5(1):9-12. 被引量:1
  • 3Zhang ZR, Duan YC. Interferon apha 2b for treating patients with JAK2V617F positive polycythemia vera and essential thrombocytosis[ J ] . Asian Pac J Cancer Prey, 2014, 15 (4) : 1681-1684.
  • 4Etheridge SL, Roh ME, Cosgrove ME, et al. JAK2V617F- positive endothelial cells contribute to clotting abnormalities in myeloproliferative neoplasms [ J ]. Proc Natl Acad Sci U S A, 2014, 111 (6) :2295-2300.
  • 5AbdE1Aal AA, Afify RA, Zaher AE, et al. Study of prognostic significance of marrow angiogenesis assessment in patients with de novo acute leukemia[ J]. Hematology, 2015, 20(9) :504-510.
  • 6Mosehetta MG, Maschio LB, Jardim-Perassi BV, et aL Prognostic value of vascular endothelial growth factor and hypoxia-indueible factor 1 c in canine malignant mammary tumors [ J ]. Oncol Rep, 2015, 33(5) :2345-2353.
  • 7Aguayo A. VEGF in chronic myeloid leukemia treated with interferon and imatinib [ J ]. Leuk Res, 2014, 38 ( 6 ) :660-661.
  • 8Tefferi A, Barbui T. Polycythemia vera and essential thrombocythemia: 2015 update on diagnosis, risk-stratification and management [ J ]. Am J Hematol, 2015, 90 ( 2 ) : 162-173.
  • 9Walz C, Crowley B J, Hudon HE, et al. Activated Jak2 with the V617F point mutation promotes G1/S phase transition [ J ]. J Biol Chem, 2006, 281 (26) :18177-18183.
  • 10Medinger M, Skoda R, Gratwohl A, et al. Angiogenesis and vascular endothelial growth factor-/receptor expression in myeloproliferative neoplasms: correlation with clinical parameters and JAK2-V617F mutational status [ J 1. Br J Haematol, 2009, 146(2) :150-157.

共引文献403

同被引文献6

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部